Remy L. Brim, Ph.D.

Affiliations: 
University of Michigan, Ann Arbor, Ann Arbor, MI 
Area:
behavioral pharmacology
Google:
"Remy Brim"
Mean distance: 16.18 (cluster 19)
 
SNBCP

Parents

Sign in to add mentor
James H. Woods grad student 2011 University of Michigan
 (Investigations into the therapeutic potential of a bacterial cocaine esterase for the treatment of cocaine toxicity and cocaine abuse.)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Collins GT, Brim RL, Noon KR, et al. (2012) Repeated administration of a mutant cocaine esterase: effects on plasma cocaine levels, cocaine-induced cardiovascular activity, and immune responses in rhesus monkeys. The Journal of Pharmacology and Experimental Therapeutics. 342: 205-13
Brim RL, Noon KR, Collins GT, et al. (2012) The fate of bacterial cocaine esterase (CocE): an in vivo study of CocE-mediated cocaine hydrolysis, CocE pharmacokinetics, and CocE elimination. The Journal of Pharmacology and Experimental Therapeutics. 340: 83-95
Brim RL, Noon KR, Collins GT, et al. (2011) The ability of bacterial cocaine esterase to hydrolyze cocaine metabolites and their simultaneous quantification using high-performance liquid chromatography-tandem mass spectrometry. Molecular Pharmacology. 80: 1119-27
Brim RL, Noon KR, Nichols J, et al. (2011) Evaluation of the hydrolytic activity of a long-acting mutant bacterial cocaine in the presence of commonly co-administered drugs. Drug and Alcohol Dependence. 119: 224-8
Brim RL, Nance MR, Youngstrom DW, et al. (2010) A thermally stable form of bacterial cocaine esterase: a potential therapeutic agent for treatment of cocaine abuse. Molecular Pharmacology. 77: 593-600
Collins GT, Brim RL, Narasimhan D, et al. (2009) Cocaine esterase prevents cocaine-induced toxicity and the ongoing intravenous self-administration of cocaine in rats. The Journal of Pharmacology and Experimental Therapeutics. 331: 445-55
See more...